On June 2–3, 2026, A3P and MabDesign will host the Bioproduction
Forum — a key meeting point for professionals driving the development
and industrialization of biopharmaceuticals.
The two-day event will
feature 12 expert talks, 24 exhibitor booths, and 4 partners, creating a
dynamic environment for insightful exchanges, innovation sharing, and
practical case-study.
This edition will spotlight mAbs, ADCs, and
biosimilars, addressing the full spectrum of challenges shaping today’s
bioproduction landscape. Attendees will have the opportunity to delve
into regulatory updates — including changes related to ICH Q1
(stability), ICH Q3E (E&L), and USP standards — while exploring new
levers for developability: template optimization, AI-driven approaches,
strategies to analyze and reduce project failures, and ways to enhance
global competitiveness.
Formulation of biological products will also
have a central role, with dedicated presentations and discussions on
best practices and innovative strategies. In line with the A3P &
MabDesign spirit, the Forum is designed to foster concrete
knowledge-sharing and meaningful interactions across industry players,
start-ups, technology providers, and service organizations.
Join us in Lausanne for two immersive days at the heart of bioproduction.
